Anticancer effect of icaritin on prostate cancer via regulating miR‐381‐3p and its target gene UBE2C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anticancer effect of icaritin on prostate cancer via regulating miR‐381‐3p and its target gene UBE2C

Published:2019-10-24 Issue:18 Volume:8 Page:7833-7845
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Hu Jimeng¹,Wu Xiaobo¹,Yang Chen¹,Rashid Khalid²,Ma Chenkai³,Hu Mengbo¹,Ding Qiang¹,Jiang Haowen¹^ORCID

Affiliation:

1. Department of Urology Huashan Hospital Fudan University Shanghai China

2. Department of Medical Oncology Zhongshan Hospital Fudan University Shanghai China

3. Department of Surgery Royal Melbourne Hospital University of Melbourne Melbourne Vic. Australia

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2630

Reference41 articles.

1. Cancer statistics, 2017

2. International trends and patterns of prostate cancer incidence and mortality

3. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

4. Regulatory mechanisms involved in the control of ubiquitin homeostasis

5. Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological actions of the bioactive compounds of Epimedium on the male reproductive system: current status and future perspective;Asian Journal of Andrology;2024-07-09

2. Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer;Journal of Experimental & Clinical Cancer Research;2024-05-23

3. A panel based on three-miRNAs as diagnostic biomarker for prostate cancer;Frontiers in Genetics;2024-05-16

4. Hyperoside Inhibits RNF8-mediated Nuclear Translocation of β-catenin to Repress PD-L1 Expression and Prostate Cancer;Anti-Cancer Agents in Medicinal Chemistry;2024-04

5. New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives;Drug Development Research;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3